#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Extra-osseous Ewing's sarcoma recurrent Neuronal ceroid lipofuscinosis Cholangiosarcoma Acquired haemophilia Epilepsy with myoclonic-atonic seizures Castleman's disease Ovarian cancer Postprandial hypoglycaemia HER2 mutant non-small cell lung cancer Juvenile psoriatic arthritis Congenital aplastic anaemia Alpha-1 antitrypsin deficiency Sickle cell anaemia Chronic myeloid leukaemia (in remission) More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Life with Disease Nephrotic syndrome Rhabdomyosarcoma recurrent Encephalitis autoimmune – Basic Information Ewing’s sarcoma recurrent – Trials in Disease Lymphangioma – Treatment Mantle cell lymphoma – Life with Disease Rhabdomyosarcoma recurrent – Treatment Choroid melanoma – Diagnostics Haemophilia B with anti factor IX – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clofutriben GS-248 Agrostis Stolonifera Pollen Bromocriptine Epinephrine Bitartrate SILYMARIN Methoxsalen Zamtocabtagene Autoleucel Bms-986435 Budesonide Lisinopril Crizanlizumab VMX-C001 ALKYLATING AGENTS Bi 764524 VTX-002 Abc-35B-116 Amikacin Sulfate Ascorbic Acid Bp Lavender Oil More therapies…

    Learn about Your Condition

    Thrombolysis Hereditary angioedema Rectal cancer recurrent Mesothelioma Immune-mediated enterocolitis Crohn's disease Metastatic neoplasm Metabolic surgery Cytomegalovirus infection Breast cancer in situ Device related infection Aortic disorder Femoral hernia Head and neck cancer stage IV Pseudomonas infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Coronary artery disease

  • Study on Clopidogrel and Acetylsalicylic Acid for Patients with Coronary Artery Disease and Non-ST-segment Elevation Acute Coronary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    The Netherlands

  • Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Coronary artery disease
    Sweden

  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Coronary artery disease
    Investigated Drugs:
    • Flecainide Acetate
    • Sotalol
    • Amiodarone Hydrochloride
    Belgium

  • Prognostic H2[15O] PET Imaging Study in Patients with Coronary Artery Disease Using O15‑Water, Adenosine and Regadenoson

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • O15-Water
    • Adenosine
    • Regadenoson
    Sweden

  • Study to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    • Placebo
    Denmark

  • A study to evaluate the effect of EA-230 on the hospital stay length for patients undergoing coronary artery bypass surgery for coronary artery disease.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • (2S)-2-[[2-[[(2S)-5-AMINO-2-[[(2S)-2-AMINOPROPANOYL]AMINO]-5-OXOPENTANOYL]AMINO]ACETYL]AMINO]-3-METHYLBUTANOIC ACID
    Belgium The Netherlands
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!